The Stevanato Group, a global provider of diagnostic solutions, drug regulations, and delivery, will present its innovative visual robot unit at Achema from 22 to 26 August.
Stevanato will provide live demonstrations of its innovative visual inspection system, a robotic system with assembly and packaging solutions, at the trade exhibition. The vision robot unit was created to investigate parenteral drugs visually.
The robotic system was developed for visually inspecting glass containers and parenteral drugs by implementing the principles of artificial intelligence to increase the performance and production efficiency levels in pharma companies.
Stevanato’s new robotic unit combines flexible manual inspection with the productivity and stability of robotics. Based on the principles of artificial intelligence, the vision robot module can inspect, without interference from humans, cosmetic and particulate defects in inspected glass containers of cartridges, syringes, vials, and drugs.
The company said that this system is suitable for multiple applications in pharmaceutical manufacturing units, including biotech products such as vaccines, lyophilized drugs, and monoclonal antibodies.
Other contributions
Apart from the vision robot, Stevanato will show a few other digital innovations developed to increase production and quality, reducing marketing time in the pharmaceutical companies at Achema.
A few examples are the artificial intelligence system applied for a visual survey and a digital twin that helps make virtual copies of the assembly machines and reduces the setup time. It helps improve performance through helpful data collection.
Stevanato will present its modular, innovative, and flexible assembly solutions at the Achema to all pharmaceutical companies. With the presence of different devices in the pharma market, modularity and flexibility of the machines are necessary to adapt to the wide range of production plans.
Due to its adaptability, Stevanato strengthens the pharmaceutical companies and contract manufacturers with a structured approach that can upgrade production, ensure flexibility and allow consumers to fasten the steps between the labs and the markets.
